Corvus Pharmaceuticals
CRVS
#8137
Rank
NZ$0.34 B
Marketcap
$5.09
Share price
-4.68%
Change (1 day)
81.62%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2023 (TTM): -$1.39

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.50. In 2022 the company made an earnings per share (EPS) of -$1.59 an increase over its 2021 EPS that were of -$1.89.

EPS history for Corvus Pharmaceuticals from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.39-12.59%
2022-$1.59-16.04%
2021-$1.89404.76%
2020-$0.38-86.79%
2019-$2.84-9.14%
2018-$3.13-35.66%
2017-$4.86-60.47%
2016-$12.29348.05%
2015-$2.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.90 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA